HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an overview of the Company’s business strategy will be given at the Oppenheimer & Co., Inc. 22nd Annual Healthcare Conference, being held at The Waldorf=Astoria Hotel in New York City. The Spectrum Pharmaceuticals presentation is at 2:45pm Eastern Time on Wednesday, December 14, 2011 in the West Foyer room.
